Showing 1 - 8 results of 8 for search 'Gal Markel', query time: 0.02s
Refine Results
-
1
Safety of BRAF+MEK Inhibitor Combinations: Severe Adverse Event Evaluation by Tomer Meirson, Nethanel Asher, David Bomze, Gal Markel
Published 2020-06-01
Article -
2
-
3
-
4
-
5
-
6
Development of allogeneic NK cell adoptive transfer therapy in metastatic melanoma patients: in vitro preclinical optimization studies. by Michal J Besser, Tsipi Shoham, Orit Harari-Steinberg, Naama Zabari, Rona Ortenberg, Arkadi Yakirevitch, Arnon Nagler, Ron Loewenthal, Jacob Schachter, Gal Markel
Published 2013-01-01
Article -
7
Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology by Tomer Meirson, Valerio Nardone, Francesca Pentimalli, Gal Markel, David Bomze, Maria D’Apolito, Pierpaolo Correale, Antonio Giordano, Luigi Pirtoli, Camillo Porta, Steven G Gray, Luciano Mutti
Published 2022-12-01
Article -
8
First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma – A real-world experience from Israel by Itamar Averbuch, Saeed Salman, Saeed Salman, Noa Shtamper, Ilana Doweck, Ilana Doweck, Aron Popovtzer, Gal Markel, Daniel Hendler, Inbar Finkel, Assaf Moore, Eyal Fenig, Tarek Taha, Kamel Mhameed, Noga Kurman, Salem Billan, Salem Billan
Published 2023-01-01
Article